<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1989-07-01" modified="2020-10-07" version="212">
<accession>P09917</accession>
<accession>B7ZLS0</accession>
<accession>E5FPY5</accession>
<accession>E5FPY7</accession>
<accession>E5FPY8</accession>
<accession>Q5JQ14</accession>
<name>LOX5_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="37">Polyunsaturated fatty acid 5-lipoxygenase</fullName>
<ecNumber evidence="30">1.13.11.-</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Arachidonate 5-lipoxygenase</fullName>
<shortName evidence="36">5-LO</shortName>
<shortName evidence="36">5-lipoxygenase</shortName>
<ecNumber evidence="23">1.13.11.34</ecNumber>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="43">ALOX5</name>
<name type="synonym">LOG5</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="Proc. Natl. Acad. Sci. U.S.A." volume="85" first="416" last="420">
<title>Cloning of the cDNA for human 5-lipoxygenase.</title>
<authorList>
<person name="Dixon R.A.F."/>
<person name="Jones R.E."/>
<person name="Diehl R.E."/>
<person name="Bennett C.D."/>
<person name="Kargman S."/>
<person name="Rouzer C.A."/>
</authorList>
<dbReference type="PubMed" id="3422434"/>
<dbReference type="DOI" id="10.1073/pnas.85.2.416"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1988" name="Proc. Natl. Acad. Sci. U.S.A." volume="85" first="26" last="30">
<title>Molecular cloning and amino acid sequence of human 5-lipoxygenase.</title>
<authorList>
<person name="Matsumoto T."/>
<person name="Funk C.D."/>
<person name="Raadmark O."/>
<person name="Hoeoeg J.-O."/>
<person name="Joernvall H."/>
<person name="Samuelsson B."/>
</authorList>
<dbReference type="PubMed" id="2829172"/>
<dbReference type="DOI" id="10.1073/pnas.85.1.26"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1988" name="Proc. Natl. Acad. Sci. U.S.A." volume="85" first="3406" last="3406">
<authorList>
<person name="Matsumoto T."/>
<person name="Funk C.D."/>
<person name="Raadmark O."/>
<person name="Hoeoeg J.-O."/>
<person name="Joernvall H."/>
<person name="Samuelsson B."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:2829172</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1989" name="Adv. Prostaglandin Thromboxane Leukotriene Res." volume="19" first="466" last="469">
<title>Molecular cloning and amino acid sequence of human 5-lipoxygenase.</title>
<authorList>
<person name="Matsumoto T."/>
<person name="Funk C.D."/>
<person name="Raadmark O."/>
<person name="Hoeoeg J.-O."/>
<person name="Joernvall H."/>
<person name="Samuelsson B."/>
</authorList>
<dbReference type="PubMed" id="2526519"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2011" name="FASEB J." volume="25" first="1097" last="1105">
<title>Novel 5-lipoxygenase isoforms affect the biosynthesis of 5-lipoxygenase products.</title>
<authorList>
<person name="Boudreau L.H."/>
<person name="Bertin J."/>
<person name="Robichaud P.P."/>
<person name="Laflamme M."/>
<person name="Ouellette R.J."/>
<person name="Flamand N."/>
<person name="Surette M.E."/>
</authorList>
<dbReference type="PubMed" id="21098726"/>
<dbReference type="DOI" id="10.1096/fj.10-173856"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4 AND 5)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nature" volume="429" first="375" last="381">
<title>The DNA sequence and comparative analysis of human chromosome 10.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Earthrowl M.E."/>
<person name="Grafham D.V."/>
<person name="Rubenfield M."/>
<person name="French L."/>
<person name="Steward C.A."/>
<person name="Sims S.K."/>
<person name="Jones M.C."/>
<person name="Searle S."/>
<person name="Scott C."/>
<person name="Howe K."/>
<person name="Hunt S.E."/>
<person name="Andrews T.D."/>
<person name="Gilbert J.G.R."/>
<person name="Swarbreck D."/>
<person name="Ashurst J.L."/>
<person name="Taylor A."/>
<person name="Battles J."/>
<person name="Bird C.P."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ashwell R.I.S."/>
<person name="Ambrose K.D."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Cahill P."/>
<person name="Camire D."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Corby N."/>
<person name="Coulson A."/>
<person name="Dhami P."/>
<person name="Dutta I."/>
<person name="Dunn M."/>
<person name="Faulkner L."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gustafson E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E."/>
<person name="Heath P.D."/>
<person name="Ho T.P."/>
<person name="Hopkins B."/>
<person name="Horne J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hynds C."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kana A."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="Kershaw J.K."/>
<person name="Kokkinaki M."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lee H.M."/>
<person name="Leongamornlert D.A."/>
<person name="Laird G."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nguyen M."/>
<person name="Overton-Larty E."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K."/>
<person name="Rice C.M."/>
<person name="Rogosin A."/>
<person name="Ross M.T."/>
<person name="Sarafidou T."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Standring L."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Torcasso W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tsolas J."/>
<person name="Wall M."/>
<person name="Walsh J."/>
<person name="Wang H."/>
<person name="Weinstock K."/>
<person name="West A.P."/>
<person name="Willey D.L."/>
<person name="Whitehead S.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Chen Y."/>
<person name="Lovering R.C."/>
<person name="Moschonas N.K."/>
<person name="Siebert R."/>
<person name="Fechtel K."/>
<person name="Bentley D."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Doucette-Stamm L."/>
<person name="Beck S."/>
<person name="Smith D.R."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="15164054"/>
<dbReference type="DOI" id="10.1038/nature02462"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1989" name="Proc. Natl. Acad. Sci. U.S.A." volume="86" first="2587" last="2591">
<title>Characterization of the human 5-lipoxygenase gene.</title>
<authorList>
<person name="Funk C.D."/>
<person name="Hoshiko S."/>
<person name="Matsumoto T."/>
<person name="Raadmark O."/>
<person name="Samuelsson B."/>
</authorList>
<dbReference type="PubMed" id="2565035"/>
<dbReference type="DOI" id="10.1073/pnas.86.8.2587"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-50</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1990" name="Proc. Natl. Acad. Sci. U.S.A." volume="87" first="9073" last="9077">
<title>Characterization of the human 5-lipoxygenase gene promoter.</title>
<authorList>
<person name="Hoshiko S."/>
<person name="Raadmark O."/>
<person name="Samuelsson B."/>
</authorList>
<dbReference type="PubMed" id="2251250"/>
<dbReference type="DOI" id="10.1073/pnas.87.23.9073"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-11</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1987" name="Proc. Natl. Acad. Sci. U.S.A." volume="84" first="7393" last="7397">
<title>Reversible, calcium-dependent membrane association of human leukocyte 5-lipoxygenase.</title>
<authorList>
<person name="Rouzer C.A."/>
<person name="Samuelsson B."/>
</authorList>
<dbReference type="PubMed" id="3118366"/>
<dbReference type="DOI" id="10.1073/pnas.84.21.7393"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="22057" last="22062">
<title>Evaluation of the role of conserved His and Met residues among lipoxygenases by site-directed mutagenesis of recombinant human 5-lipoxygenase.</title>
<authorList>
<person name="Nguyen T."/>
<person name="Falgueyret J.-P."/>
<person name="Abramowitz M."/>
<person name="Riendeau D."/>
</authorList>
<dbReference type="PubMed" id="1939225"/>
</citation>
<scope>MUTAGENESIS OF HIS-363; HIS-368; HIS-373; HIS-391 AND HIS-400</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1992" name="Biochem. Biophys. Res. Commun." volume="182" first="1482" last="1490">
<title>Mutagenesis studies on the amino acid residues involved in the iron-binding and the activity of human 5-lipoxygenase.</title>
<authorList>
<person name="Ishii S."/>
<person name="Noguchi M."/>
<person name="Miyano M."/>
<person name="Matsumoto T."/>
<person name="Noma M."/>
</authorList>
<dbReference type="PubMed" id="1540191"/>
<dbReference type="DOI" id="10.1016/0006-291x(92)91901-2"/>
</citation>
<scope>MUTAGENESIS OF HIS-368; HIS-373; GLU-377; HIS-391; HIS-400 AND HIS-551</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1993" name="J. Exp. Med." volume="178" first="1935" last="1946">
<title>5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes.</title>
<authorList>
<person name="Woods J.W."/>
<person name="Evans J.F."/>
<person name="Ethier D."/>
<person name="Scott S."/>
<person name="Vickers P.J."/>
<person name="Hearn L."/>
<person name="Heibein J.A."/>
<person name="Charleson S."/>
<person name="Singer I.I."/>
</authorList>
<dbReference type="PubMed" id="8245774"/>
<dbReference type="DOI" id="10.1084/jem.178.6.1935"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="24163" last="24168">
<title>5-Lipoxygenase contains a functional Src homology 3-binding motif that interacts with the Src homology 3 domain of Grb2 and cytoskeletal proteins.</title>
<authorList>
<person name="Lepley R.A."/>
<person name="Fitzpatrick F.A."/>
</authorList>
<dbReference type="PubMed" id="7929073"/>
</citation>
<scope>INTERACTION WITH GRB2</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1996" name="Biochem. J." volume="314" first="911" last="916">
<title>The suppression of 5-lipoxygenation of arachidonic acid in human polymorphonuclear leucocytes by the 15-lipoxygenase product (15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid: structure-activity relationship and mechanism of action.</title>
<authorList>
<person name="Petrich K."/>
<person name="Ludwig P."/>
<person name="Kuehn H."/>
<person name="Schewe T."/>
</authorList>
<dbReference type="PubMed" id="8615788"/>
<dbReference type="DOI" id="10.1042/bj3140911"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1996" name="Eur. J. Biochem." volume="235" first="416" last="423">
<title>Oxidative inactivation of human 5-lipoxygenase in phosphatidylcholine vesicles.</title>
<authorList>
<person name="De Carolis E."/>
<person name="Denis D."/>
<person name="Riendeau D."/>
</authorList>
<dbReference type="PubMed" id="8631361"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1996.00416.x"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="14793" last="14800">
<title>Arachidonic acid promotes phosphorylation of 5-lipoxygenase at Ser-271 by MAPK-activated protein kinase 2 (MK2).</title>
<authorList>
<person name="Werz O."/>
<person name="Szellas D."/>
<person name="Steinhilber D."/>
<person name="Radmark O."/>
</authorList>
<dbReference type="PubMed" id="11844797"/>
<dbReference type="DOI" id="10.1074/jbc.m111945200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-272</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="41512" last="41520">
<title>Protein kinase A inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523.</title>
<authorList>
<person name="Luo M."/>
<person name="Jones S.M."/>
<person name="Phare S.M."/>
<person name="Coffey M.J."/>
<person name="Peters-Golden M."/>
<person name="Brock T.G."/>
</authorList>
<dbReference type="PubMed" id="15280375"/>
<dbReference type="DOI" id="10.1074/jbc.m312568200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-524</scope>
<scope>MUTAGENESIS OF SER-524</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Chem. Biol." volume="13" first="1193" last="1202">
<title>Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis.</title>
<authorList>
<person name="Tjonahen E."/>
<person name="Oh S.F."/>
<person name="Siegelman J."/>
<person name="Elangovan S."/>
<person name="Percarpio K.B."/>
<person name="Hong S."/>
<person name="Arita M."/>
<person name="Serhan C.N."/>
</authorList>
<dbReference type="PubMed" id="17114001"/>
<dbReference type="DOI" id="10.1016/j.chembiol.2006.09.011"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="129" last="136">
<title>Arachidonic acid regulates the translocation of 5-lipoxygenase to the nuclear membranes in human neutrophils.</title>
<authorList>
<person name="Flamand N."/>
<person name="Lefebvre J."/>
<person name="Surette M.E."/>
<person name="Picard S."/>
<person name="Borgeat P."/>
</authorList>
<dbReference type="PubMed" id="16275640"/>
<dbReference type="DOI" id="10.1074/jbc.m506513200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Biochim. Biophys. Acta" volume="1789" first="99" last="108">
<title>Human Dicer C-terminus functions as a 5-lipoxygenase binding domain.</title>
<authorList>
<person name="Dincbas-Renqvist V."/>
<person name="Pepin G."/>
<person name="Rakonjac M."/>
<person name="Plante I."/>
<person name="Ouellet D.L."/>
<person name="Hermansson A."/>
<person name="Goulet I."/>
<person name="Doucet J."/>
<person name="Samuelsson B."/>
<person name="Raadmark O."/>
<person name="Provost P."/>
</authorList>
<dbReference type="PubMed" id="19022417"/>
<dbReference type="DOI" id="10.1016/j.bbagrm.2008.10.002"/>
</citation>
<scope>INTERACTION WITH DICER1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF TRP-14; TRP-76 AND TRP-103</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Biochem. Biophys. Res. Commun." volume="381" first="518" last="522">
<title>Distinct parts of leukotriene C(4) synthase interact with 5-lipoxygenase and 5-lipoxygenase activating protein.</title>
<authorList>
<person name="Strid T."/>
<person name="Svartz J."/>
<person name="Franck N."/>
<person name="Hallin E."/>
<person name="Ingelsson B."/>
<person name="Soederstroem M."/>
<person name="Hammarstroem S."/>
</authorList>
<dbReference type="PubMed" id="19233132"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2009.02.074"/>
</citation>
<scope>INTERACTION WITH ALOX5AP AND LTC4S</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="306" last="313">
<title>Phosphorylation of serine 271 on 5-lipoxygenase and its role in nuclear export.</title>
<authorList>
<person name="Flamand N."/>
<person name="Luo M."/>
<person name="Peters-Golden M."/>
<person name="Brock T.G."/>
</authorList>
<dbReference type="PubMed" id="18978352"/>
<dbReference type="DOI" id="10.1074/jbc.m805593200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-272</scope>
<scope>MUTAGENESIS OF SER-272</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="Biochem. J." volume="425" first="265" last="274">
<title>Coactosin-like protein functions as a stabilizing chaperone for 5-lipoxygenase: role of tryptophan 102.</title>
<authorList>
<person name="Esser J."/>
<person name="Rakonjac M."/>
<person name="Hofmann B."/>
<person name="Fischer L."/>
<person name="Provost P."/>
<person name="Schneider G."/>
<person name="Steinhilber D."/>
<person name="Samuelsson B."/>
<person name="Radmark O."/>
</authorList>
<dbReference type="PubMed" id="19807693"/>
<dbReference type="DOI" id="10.1042/bj20090856"/>
</citation>
<scope>INTERACTION WITH COTL1</scope>
<scope>MUTAGENESIS OF TRP-103</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="Exp. Mol. Med." volume="43" first="101" last="110">
<title>Ligation of CD40 receptor in human B lymphocytes triggers the 5-lipoxygenase pathway to produce reactive oxygen species and activate p38 MAPK.</title>
<authorList>
<person name="Ha Y.J."/>
<person name="Seul H.J."/>
<person name="Lee J.R."/>
</authorList>
<dbReference type="PubMed" id="21200133"/>
<dbReference type="DOI" id="10.3858/emm.2011.43.2.012"/>
</citation>
<scope>INTERACTION WITH PIK3R1</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="J. Clin. Invest." volume="121" first="569" last="581">
<title>Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation.</title>
<authorList>
<person name="Oh S.F."/>
<person name="Pillai P.S."/>
<person name="Recchiuti A."/>
<person name="Yang R."/>
<person name="Serhan C.N."/>
</authorList>
<dbReference type="PubMed" id="21206090"/>
<dbReference type="DOI" id="10.1172/jci42545"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2013" name="Arch. Biochem. Biophys." volume="530" first="40" last="47">
<title>Conversion of pro-inflammatory murine Alox5 into an anti-inflammatory 15S-lipoxygenating enzyme by multiple mutations of sequence determinants.</title>
<authorList>
<person name="Hofheinz K."/>
<person name="Kakularam K.R."/>
<person name="Adel S."/>
<person name="Anton M."/>
<person name="Polymarasetty A."/>
<person name="Reddanna P."/>
<person name="Kuhn H."/>
<person name="Horn T."/>
</authorList>
<dbReference type="PubMed" id="23246375"/>
<dbReference type="DOI" id="10.1016/j.abb.2012.11.015"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF PHE-360; ALA-425; ASN-426 AND ALA-604</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2013" name="Redox Biol." volume="1" first="566" last="577">
<title>Functional characterization of genetic enzyme variations in human lipoxygenases.</title>
<authorList>
<person name="Horn T."/>
<person name="Reddy Kakularam K."/>
<person name="Anton M."/>
<person name="Richter C."/>
<person name="Reddanna P."/>
<person name="Kuhn H."/>
</authorList>
<dbReference type="PubMed" id="24282679"/>
<dbReference type="DOI" id="10.1016/j.redox.2013.11.001"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>VARIANTS LYS-254; SER-337; SER-447; VAL-549; LEU-577; MET-591 AND GLN-656</scope>
<scope>CHARACTERIZATION OF VARIANTS LYS-254; SER-337; SER-447; VAL-549; LEU-577; MET-591 AND GLN-656</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2014" name="Biochemistry" volume="53" first="4407" last="4419">
<title>ATP allosterically activates the human 5-lipoxygenase molecular mechanism of arachidonic acid and 5(S)-hydroperoxy-6(E),8(Z),11(Z),14(Z)-eicosatetraenoic acid.</title>
<authorList>
<person name="Smyrniotis C.J."/>
<person name="Barbour S.R."/>
<person name="Xia Z."/>
<person name="Hixon M.S."/>
<person name="Holman T.R."/>
</authorList>
<dbReference type="PubMed" id="24893149"/>
<dbReference type="DOI" id="10.1021/bi401621d"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>INDUCTION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2015" name="Prostaglandins Leukot. Essent. Fatty Acids" volume="100" first="33" last="40">
<title>Phosphorylation of serine 523 on 5-lipoxygenase in human B lymphocytes.</title>
<authorList>
<person name="Mahshid Y."/>
<person name="Markoutsa S."/>
<person name="Dincbas-Renqvist V."/>
<person name="Sueruen D."/>
<person name="Christensson B."/>
<person name="Sander B."/>
<person name="Bjoerkholm M."/>
<person name="Sorg B.L."/>
<person name="Raadmark O."/>
<person name="Claesson H.E."/>
</authorList>
<dbReference type="PubMed" id="26210919"/>
<dbReference type="DOI" id="10.1016/j.plefa.2015.06.003"/>
</citation>
<scope>PHOSPHORYLATION AT SER-524</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2019" name="ACS Chem. Biol." volume="14" first="2768" last="2782">
<title>Mutations of Triad Determinants Changes the Substrate Alignment at the Catalytic Center of Human ALOX5.</title>
<authorList>
<person name="Ivanov I."/>
<person name="Golovanov A.B."/>
<person name="Ferretti C."/>
<person name="Canyelles-Nino M."/>
<person name="Heydeck D."/>
<person name="Stehling S."/>
<person name="Lluch J.M."/>
<person name="Gonzalez-Lafont A."/>
<person name="Kuehn H."/>
</authorList>
<dbReference type="PubMed" id="31664810"/>
<dbReference type="DOI" id="10.1021/acschembio.9b00674"/>
</citation>
<scope>MUTAGENESIS OF PHE-360; ALA-425; ASN-426 AND ALA-604</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="32" evidence="1">
<citation type="journal article" date="2011" name="Science" volume="331" first="217" last="219">
<title>The structure of human 5-lipoxygenase.</title>
<authorList>
<person name="Gilbert N.C."/>
<person name="Bartlett S.G."/>
<person name="Waight M.T."/>
<person name="Neau D.B."/>
<person name="Boeglin W.E."/>
<person name="Brash A.R."/>
<person name="Newcomer M.E."/>
</authorList>
<dbReference type="PubMed" id="21233389"/>
<dbReference type="DOI" id="10.1126/science.1197203"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH IRON ION</scope>
<scope>COFACTOR</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="33" evidence="2 3 4">
<citation type="journal article" date="2012" name="FASEB J." volume="26" first="3222" last="3229">
<title>Conversion of human 5-lipoxygenase to a 15-lipoxygenase by a point mutation to mimic phosphorylation at Serine-663.</title>
<authorList>
<person name="Gilbert N.C."/>
<person name="Rui Z."/>
<person name="Neau D.B."/>
<person name="Waight M.T."/>
<person name="Bartlett S.G."/>
<person name="Boeglin W.E."/>
<person name="Brash A.R."/>
<person name="Newcomer M.E."/>
</authorList>
<dbReference type="PubMed" id="22516296"/>
<dbReference type="DOI" id="10.1096/fj.12-205286"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) IN COMPLEX WITH IRON ION AND ARACHIDONIC ACID</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF SER-664</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2004" name="Carcinogenesis" volume="25" first="2467" last="2472">
<title>Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk.</title>
<authorList>
<person name="Goodman J.E."/>
<person name="Bowman E.D."/>
<person name="Chanock S.J."/>
<person name="Alberg A.J."/>
<person name="Harris C.C."/>
</authorList>
<dbReference type="PubMed" id="15308583"/>
<dbReference type="DOI" id="10.1093/carcin/bgh260"/>
</citation>
<scope>VARIANT LYS-254</scope>
</reference>
<comment type="function">
<text evidence="7 15 17 21 22 23 24 25 26 27 30 32 33">Catalyzes the oxygenation of arachidonic acid to 5-hydroperoxyicosatetraenoic acid (5-HPETE) followed by the dehydration of the hydroperoxide into an epoxide, 5,6- oxidoicosatetraenoic acid (LTA4), thereby participates in the first step in leukotriene biosynthesis and in the inflammatory processes (PubMed:8631361, PubMed:21233389, PubMed:22516296, PubMed:24282679, PubMed:19022417, PubMed:23246375, PubMed:8615788, PubMed:24893149, PubMed:31664810). Also catalyzes the oxygenation of arachidonic acid into 8-hydroperoxyicosatetraenoic acid (8-HPETE) and 12-hydroperoxyicosatetraenoic acid (12-HPETE) (PubMed:23246375). Although arachidonic acid is the preferred substrate, can also metabolize oxidized fatty acids derived from arachidonic acid such as (15S)-HETE, eicosapentaenoic acid (EPA) such as (18R)- and (18S)-HEPE or docosahexaenoic (DHA) acid which leads to the formation of specialized pro-resolving mediators (SPM) lipoxin and resolvins E and D respectively, therefore plays a role in anti-inflammatory response (PubMed:21206090, PubMed:31664810, PubMed:8615788, PubMed:17114001). Also displays lipoxin synthase activity being able to convert (15S)-HETE into a conjugate tetraene (PubMed:31664810). Oxidation of docosahexaenoic acid directly inhibits endothelial cell proliferation and sprouting angiogenesis via peroxisome proliferator-activated receptor gamma (PPARgamma) (By similarity). Does not catalyze the oxygenation of linoleic acid and does not convert (5S)-HETE to lipoxins isomers (PubMed:31664810). In addition to inflammatory processes, participates in dendritic cell migration, wound healing through an antioxidant mechanism based on HO1 regulation expression, monocyte adhesion to the endothelium via ITGAM expression on monocytes (By similarity). Moreover, establishes an adaptive humoral immunity by regulating primary resting B cells and follicular helper T cells and participates in the CD40-induced production of reactive oxygen species (ROS) after CD40 ligation in B cells through interaction with PIK3R1 that bridges ALOX5 with CD40 (PubMed:21200133). Also may play a role in glucose homeostasis, regulation of INS secretion and palmitic acid-induced insulin resistance via AMPK (By similarity). Can regulate bone mineralization and fat cell differentiation increases in induced pluripotent stem cells (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="17 23">
<text>(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = H2O + leukotriene A4</text>
<dbReference type="Rhea" id="RHEA:32307"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:32395"/>
<dbReference type="ChEBI" id="CHEBI:57463"/>
<dbReference type="EC" id="1.13.11.34"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="23">
<dbReference type="Rhea" id="RHEA:32308"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="15">
<text>18-HEPE + O2 = (5S)-hydroperoxy-18-hydroxy-(7E,9E,11Z,14Z,16E)-eicosapentaenoate</text>
<dbReference type="Rhea" id="RHEA:48860"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:90825"/>
<dbReference type="ChEBI" id="CHEBI:90826"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="38">
<dbReference type="Rhea" id="RHEA:48861"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="22">
<text>(18R)-hydroxy-(5Z,8Z,11Z,14Z,16E)-eicosapentaenoate + O2 = (5S)-hydroperoxy-(18R)-hydroxy-(6E,8Z,11Z,14Z,16E)-eicosapentaenoate</text>
<dbReference type="Rhea" id="RHEA:51968"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:90818"/>
<dbReference type="ChEBI" id="CHEBI:132218"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="39">
<dbReference type="Rhea" id="RHEA:51969"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="22">
<text>(18S)-hydroxy-(5Z,8Z,11Z,14Z,16E)-eicosapentaenoate + O2 = (5S)-hydroperoxy-(18S)-hydroxy-(6E,8Z,11Z,14Z,16E)-eicosapentaenoate</text>
<dbReference type="Rhea" id="RHEA:50204"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:132083"/>
<dbReference type="ChEBI" id="CHEBI:132091"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="39">
<dbReference type="Rhea" id="RHEA:50205"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="22">
<text>(5S)-hydroperoxy-(18S)-hydroxy-(6E,8Z,11Z,14Z,16E)-eicosapentaenoate = (5S,6S)-epoxy-(18S)-hydroxy-(7E,9E,11Z,14Z,16E)-eicosapentaenoate + H2O</text>
<dbReference type="Rhea" id="RHEA:39107"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:132091"/>
<dbReference type="ChEBI" id="CHEBI:134661"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="39">
<dbReference type="Rhea" id="RHEA:39108"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="22 38">
<text>(5S)-hydroperoxy-(18R)-hydroxy-(6E,8Z,11Z,14Z,16E)-eicosapentaenoate = (5S,6S)-epoxy-(18R)-hydroxy-(7E,9E,11Z,14Z,16E)-eicosapentaenoate + H2O</text>
<dbReference type="Rhea" id="RHEA:50268"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:132218"/>
<dbReference type="ChEBI" id="CHEBI:132219"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="39">
<dbReference type="Rhea" id="RHEA:50269"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="15">
<text>(5S)-hydroperoxy-18-hydroxy-(7E,9E,11Z,14Z,16E)-eicosapentaenoate = (5S,6S)-epoxy-18-hydroxy-(7E,9E,11Z,14Z,16E)-eicosapentaenoate + H2O</text>
<dbReference type="Rhea" id="RHEA:50844"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:90826"/>
<dbReference type="ChEBI" id="CHEBI:133812"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="38">
<dbReference type="Rhea" id="RHEA:50845"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="17 24 25 26 27 32 33">
<text>(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = (5S)-hydroperoxy-(6E,8Z,11Z,14Z)-eicosatetraenoate</text>
<dbReference type="Rhea" id="RHEA:17485"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:32395"/>
<dbReference type="ChEBI" id="CHEBI:57450"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="42">
<dbReference type="Rhea" id="RHEA:17486"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="30 32">
<text>(5Z,8Z,11Z,13E,15S)-hydroxyeicosatetraenoate + O2 = (5S)-hydroperoxy-(15S)-hydroxy-(6E,8Z,11Z,13E)-eicosatetraenoate</text>
<dbReference type="Rhea" id="RHEA:48624"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:57409"/>
<dbReference type="ChEBI" id="CHEBI:131564"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="32">
<dbReference type="Rhea" id="RHEA:48625"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="26 27 33">
<text>(5S)-hydroperoxy-(6E,8Z,11Z,14Z)-eicosatetraenoate = H2O + leukotriene A4</text>
<dbReference type="Rhea" id="RHEA:17961"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:57450"/>
<dbReference type="ChEBI" id="CHEBI:57463"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="42">
<dbReference type="Rhea" id="RHEA:17962"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="25">
<text>(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = (8S)-hydroperoxy-(5Z,9E,11Z,14Z)-eicosatetraenoate</text>
<dbReference type="Rhea" id="RHEA:38675"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:32395"/>
<dbReference type="ChEBI" id="CHEBI:75322"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="40">
<dbReference type="Rhea" id="RHEA:38676"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="25">
<text>(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = (12S)-hydroperoxy-(5Z,8Z,10E,14Z)-eicosatetraenoate</text>
<dbReference type="Rhea" id="RHEA:10428"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:32395"/>
<dbReference type="ChEBI" id="CHEBI:57444"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="40">
<dbReference type="Rhea" id="RHEA:10429"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="42">
<text>(5Z,8Z)-eicosadienoate + O2 = (5S)-hydroperoxy-(6E,8Z)-eicosadienoate</text>
<dbReference type="Rhea" id="RHEA:62644"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:145835"/>
<dbReference type="ChEBI" id="CHEBI:145836"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="42">
<text>(12S)-hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoate + O2 = (5S)-hydroperoxy-(12S)-hydroxy-(6E,8Z,10E,14Z)-eicosatetraenoate</text>
<dbReference type="Rhea" id="RHEA:62648"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:90680"/>
<dbReference type="ChEBI" id="CHEBI:145837"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="30">
<text>(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + O2 = 5-hydroperoxy-(6E,8Z,11Z,14Z,17Z)-eicosapentaenoate</text>
<dbReference type="Rhea" id="RHEA:62600"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:58562"/>
<dbReference type="ChEBI" id="CHEBI:145815"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="41">
<dbReference type="Rhea" id="RHEA:62601"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="30">
<text>(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate + O2 = 7-hydroperoxy-(4Z,8E,10Z,13Z,16Z,19Z)-docosahexaenoate</text>
<dbReference type="Rhea" id="RHEA:62604"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:77016"/>
<dbReference type="ChEBI" id="CHEBI:145816"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="41">
<dbReference type="Rhea" id="RHEA:62605"/>
</physiologicalReaction>
</comment>
<comment type="cofactor">
<cofactor evidence="9 23">
<name>Fe cation</name>
<dbReference type="ChEBI" id="CHEBI:24875"/>
</cofactor>
<text evidence="9 23">Binds 1 Fe cation per subunit.</text>
</comment>
<comment type="activity regulation">
<text evidence="27 32 33">Undergoes a sequential loss of the oxygenase and pseudoperoxidase activities which is dependent on the structural characteristics of the substrate for the reaction, on oxygen concentration and on exposure to phospholipids and calcium (PubMed:8631361). 15-HETE and other 15-mono-hydroxyeicosanoids exhibit the highest inhibitory potencies in their capability of suppressing 5-lipoxygenation of arachidonic acid, whereas the other HETEs, (5S,15S)-dihydroxy-(6E,8Z,11Z,13E)-eicosatetraenoic acid (5,15-diHETE) as well as octadecanoids, are modest or poor inhibitors (PubMed:8615788). The formation of (5S)-hydroperoxy-(15S)-hydroxy-(6E,8Z,11Z,13E)-eicosatetraenoate is strongly stimulated by either hydroperoxypolyenoic fatty acids or arachidonic acid (PubMed:8615788). Arachidonate 5-lipoxygenase and leukotriene A4 synthase activities are allosterically increased by ATP (PubMed:24893149).</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="33">13 uM for (5S)-hydroperoxy-(6E,8Z,11Z,14Z)-eicosatetraenoate</KM>
<KM evidence="24">11 uM for arachidonic acid</KM>
<KM evidence="27">1.9 uM for arachidonic acid</KM>
<KM evidence="27">14 uM for (5S)-hydroperoxy-(6E,8Z,11Z,14Z)-eicosatetraenoate</KM>
<KM evidence="27">5.3 uM for arachidonic acid (in the presence of 200 uM ATP)</KM>
<KM evidence="27">19 uM for (5S)-hydroperoxy-(6E,8Z,11Z,14Z)-eicosatetraenoate (in the presence of 200 uM ATP)</KM>
<KM evidence="27">1.6 uM for (5S)-hydroperoxy-(6E,8Z,11Z,14Z)-eicosatetraenoate (generated in situ from arachidonic acid)</KM>
<KM evidence="27">4.5 uM for (5S)-hydroperoxy-(6E,8Z,11Z,14Z)-eicosatetraenoate (generated in situ from arachidonic acid in the presence of 200 uM ATP)</KM>
<Vmax evidence="27">1 umol/min/mg enzyme toward arachidonic acid</Vmax>
<Vmax evidence="27">0.33 umol/min/mg enzyme toward (5S)-hydroperoxy-(6E,8Z,11Z,14Z)-eicosatetraenoate</Vmax>
<Vmax evidence="27">4.9 umol/min/mg enzyme toward arachidonic acid (in the presence of 200 uM ATP)</Vmax>
<Vmax evidence="27">1.6 umol/min/mg enzyme toward (5S)-hydroperoxy-(6E,8Z,11Z,14Z)-eicosatetraenoate (in the presence of 200 uM ATP)</Vmax>
<Vmax evidence="27">0.1 umol/min/mg enzyme toward (5S)-hydroperoxy-(6E,8Z,11Z,14Z)-eicosatetraenoate (generated in situ from arachidonic acid)</Vmax>
<Vmax evidence="27">2 umol/min/mg enzyme toward (5S)-hydroperoxy-(6E,8Z,11Z,14Z)-eicosatetraenoate (generated in situ from arachidonic acid in the presence of 200 uM ATP)</Vmax>
</kinetics>
</comment>
<comment type="pathway" evidence="33">
<text>Lipid metabolism; leukotriene A4 biosynthesis.</text>
</comment>
<comment type="subunit">
<text evidence="17 18 20 21 23 24">Homodimer (PubMed:22516296, PubMed:21233389). Interacts with ALOX5AP and LTC4S (PubMed:19233132). Interacts with COTL1, the interaction is required for stability and efficient catalytic activity (PubMed:19807693). Interacts with PIK3R1; this interaction bridges ALOX5 with CD40 after CD40 ligation in B cells and leads to the production of reactive oxygen species (ROS) (PubMed:21200133). Interacts (via PLAT domain) with DICER1 (via Dicer dsRNA-binding fold domain); this interaction enhances arachidonate 5-lipoxygenase activity and modifies the miRNA precursor processing activity of DICER1 (PubMed:19022417).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-13381098">
<id>Q8IYJ2-2</id>
<label>C10orf67</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-747830">
<id>Q6PII3</id>
<label>CCDC174</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-12696312">
<id>Q6P2R3</id>
<label>CEP57L1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-10181988">
<id>Q8IYX8-2</id>
<label>CEP57L1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-741977">
<id>Q96MT8</id>
<label>CEP63</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-11522539">
<id>Q96MT8-3</id>
<label>CEP63</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-79926">
<id>Q14019</id>
<label>COTL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-1383732">
<id>P09769</id>
<label>FGR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-6929453">
<id>O43716</id>
<label>GATC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-346340">
<id>P08631</id>
<label>HCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-10196655">
<id>Q6UWX4</id>
<label>HHIPL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-12867244">
<id>P14061</id>
<label>HSD17B1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-1052433">
<id>P31025</id>
<label>LCN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-742610">
<id>Q9Y6D9</id>
<label>MAD1L1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-2864512">
<id>P50221</id>
<label>MEOX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-16439278">
<id>Q6FHY5</id>
<label>MEOX2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-10178410">
<id>Q86Y26</id>
<label>NUTM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-18583589">
<id>A6NGQ2</id>
<label>OOEP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-476586">
<id>P17612</id>
<label>PRKACA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-307352">
<id>Q04864</id>
<label>REL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-6872807">
<id>Q8N0S2</id>
<label>SYCE1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-3258000">
<id>Q9P0N9</id>
<label>TBC1D7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79934">
<id>P09917</id>
</interactant>
<interactant intactId="EBI-515331">
<id>P07947</id>
<label>YES1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="7 16">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="18">Nucleus matrix</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="14">Nucleus membrane</location>
<topology evidence="14">Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="17">Cytoplasm</location>
<location evidence="17">Perinuclear region</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="18">Cytoplasm</location>
<location evidence="18">Cytosol</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="14 18 31">Nucleus envelope</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="31">Nucleus intermembrane space</location>
</subcellularLocation>
<text evidence="14 16 18 29 31">Shuttles between cytoplasm and nucleus (PubMed:19233132). Found exclusively in the nucleus, when phosphorylated on Ser-272 (PubMed:18978352). Calcium binding promotes translocation from the cytosol and the nuclear matrix to the nuclear envelope and membrane association (PubMed:19233132, PubMed:3118366, PubMed:8245774, PubMed:16275640).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P09917-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P09917-2</id>
<name>2</name>
<name>Delta-13</name>
<sequence type="described" ref="VSP_046998"/>
</isoform>
<isoform>
<id>P09917-3</id>
<name>3</name>
<name>delta-p10</name>
<sequence type="described" ref="VSP_053534"/>
</isoform>
<isoform>
<id>P09917-4</id>
<name>4</name>
<name>delta-10-13</name>
<sequence type="described" ref="VSP_053535 VSP_053537"/>
</isoform>
<isoform>
<id>P09917-5</id>
<name>5</name>
<name>alpha-10</name>
<sequence type="described" ref="VSP_053536"/>
</isoform>
<text>Additional isoforms seem to exist.</text>
</comment>
<comment type="PTM">
<text evidence="10 11 16 28">Serine phosphorylation by MAPKAPK2 is stimulated by arachidonic acid (PubMed:11844797, PubMed:18978352). Phosphorylation on Ser-524 by PKA has an inhibitory effect (PubMed:15280375). Phosphorylation on Ser-272 prevents export from the nucleus (PubMed:11844797, PubMed:18978352). Phosphorylation at Ser-524 is stimulated by 8-bromo-3',5'-cyclic AMP or prostaglandin E2 (PubMed:26210919).</text>
</comment>
<comment type="similarity">
<text evidence="37">Belongs to the lipoxygenase family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/ALOX5ID42985ch10q11.html"/>
</comment>
<dbReference type="EC" id="1.13.11.-" evidence="30"/>
<dbReference type="EC" id="1.13.11.34" evidence="23"/>
<dbReference type="EMBL" id="J03600">
<property type="protein sequence ID" value="AAA36183.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="J03571">
<property type="protein sequence ID" value="AAA65450.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="HM592258">
<property type="protein sequence ID" value="ADR30798.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="HM592259">
<property type="protein sequence ID" value="ADR30799.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="HM592260">
<property type="protein sequence ID" value="ADR30800.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="HM592261">
<property type="protein sequence ID" value="ADR30801.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="J04520">
<property type="protein sequence ID" value="AAA59522.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL731567">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC130332">
<property type="protein sequence ID" value="AAI30333.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC132677">
<property type="protein sequence ID" value="AAI32678.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC143985">
<property type="protein sequence ID" value="AAI43986.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M38191">
<property type="protein sequence ID" value="AAA63212.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58078.1">
<molecule id="P09917-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7212.1">
<molecule id="P09917-1"/>
</dbReference>
<dbReference type="PIR" id="A28117">
<property type="entry name" value="DAHUAL"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000689.1">
<molecule id="P09917-1"/>
<property type="nucleotide sequence ID" value="NM_000698.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001243082.1">
<molecule id="P09917-3"/>
<property type="nucleotide sequence ID" value="NM_001256153.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001243083.1">
<molecule id="P09917-2"/>
<property type="nucleotide sequence ID" value="NM_001256154.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001307790.1">
<property type="nucleotide sequence ID" value="NM_001320861.1"/>
</dbReference>
<dbReference type="PDB" id="2ABV">
<property type="method" value="Model"/>
<property type="chains" value="A=2-674"/>
</dbReference>
<dbReference type="PDB" id="3O8Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.39"/>
<property type="chains" value="A/B=1-674"/>
</dbReference>
<dbReference type="PDB" id="3V92">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.74"/>
<property type="chains" value="A/B=1-674"/>
</dbReference>
<dbReference type="PDB" id="3V98">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.07"/>
<property type="chains" value="A/B=1-674"/>
</dbReference>
<dbReference type="PDB" id="3V99">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A/B=1-674"/>
</dbReference>
<dbReference type="PDB" id="6N2W">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.71"/>
<property type="chains" value="A/B=1-674"/>
</dbReference>
<dbReference type="PDB" id="6NCF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.87"/>
<property type="chains" value="A/B/C/D=1-674"/>
</dbReference>
<dbReference type="PDBsum" id="2ABV"/>
<dbReference type="PDBsum" id="3O8Y"/>
<dbReference type="PDBsum" id="3V92"/>
<dbReference type="PDBsum" id="3V98"/>
<dbReference type="PDBsum" id="3V99"/>
<dbReference type="PDBsum" id="6N2W"/>
<dbReference type="PDBsum" id="6NCF"/>
<dbReference type="SMR" id="P09917"/>
<dbReference type="BioGRID" id="106741">
<property type="interactions" value="71"/>
</dbReference>
<dbReference type="DIP" id="DIP-30950N"/>
<dbReference type="IntAct" id="P09917">
<property type="interactions" value="64"/>
</dbReference>
<dbReference type="MINT" id="P09917"/>
<dbReference type="STRING" id="9606.ENSP00000363512"/>
<dbReference type="BindingDB" id="P09917"/>
<dbReference type="ChEMBL" id="CHEMBL215"/>
<dbReference type="DrugBank" id="DB14001">
<property type="generic name" value="alpha-Tocopherol succinate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00233">
<property type="generic name" value="Aminosalicylic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01014">
<property type="generic name" value="Balsalazide"/>
</dbReference>
<dbReference type="DrugBank" id="DB09061">
<property type="generic name" value="Cannabidiol"/>
</dbReference>
<dbReference type="DrugBank" id="DB14002">
<property type="generic name" value="D-alpha-Tocopherol acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB11994">
<property type="generic name" value="Diacerein"/>
</dbReference>
<dbReference type="DrugBank" id="DB00586">
<property type="generic name" value="Diclofenac"/>
</dbReference>
<dbReference type="DrugBank" id="DB00711">
<property type="generic name" value="Diethylcarbamazine"/>
</dbReference>
<dbReference type="DrugBank" id="DB12010">
<property type="generic name" value="Fostamatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01892">
<property type="generic name" value="Hyperforin"/>
</dbReference>
<dbReference type="DrugBank" id="DB04725">
<property type="generic name" value="Licofelone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00179">
<property type="generic name" value="Masoprocol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00939">
<property type="generic name" value="Meclofenamic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB14009">
<property type="generic name" value="Medical Cannabis"/>
</dbReference>
<dbReference type="DrugBank" id="DB00244">
<property type="generic name" value="Mesalazine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01017">
<property type="generic name" value="Minocycline"/>
</dbReference>
<dbReference type="DrugBank" id="DB05431">
<property type="generic name" value="MLN-977"/>
</dbReference>
<dbReference type="DrugBank" id="DB00471">
<property type="generic name" value="Montelukast"/>
</dbReference>
<dbReference type="DrugBank" id="DB09285">
<property type="generic name" value="Morniflumate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14011">
<property type="generic name" value="Nabiximols"/>
</dbReference>
<dbReference type="DrugBank" id="DB11133">
<property type="generic name" value="Omega-3 fatty acids"/>
</dbReference>
<dbReference type="DrugBank" id="DB13168">
<property type="generic name" value="Omega-6 fatty acids"/>
</dbReference>
<dbReference type="DrugBank" id="DB02709">
<property type="generic name" value="Resveratrol"/>
</dbReference>
<dbReference type="DrugBank" id="DB13174">
<property type="generic name" value="Rhein"/>
</dbReference>
<dbReference type="DrugBank" id="DB00795">
<property type="generic name" value="Sulfasalazine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00163">
<property type="generic name" value="Vitamin E"/>
</dbReference>
<dbReference type="DrugBank" id="DB00744">
<property type="generic name" value="Zileuton"/>
</dbReference>
<dbReference type="DrugCentral" id="P09917"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1385"/>
<dbReference type="SwissLipids" id="SLP:000000669"/>
<dbReference type="iPTMnet" id="P09917"/>
<dbReference type="PhosphoSitePlus" id="P09917"/>
<dbReference type="BioMuta" id="ALOX5"/>
<dbReference type="DMDM" id="126407"/>
<dbReference type="jPOST" id="P09917"/>
<dbReference type="MassIVE" id="P09917"/>
<dbReference type="MaxQB" id="P09917"/>
<dbReference type="PaxDb" id="P09917"/>
<dbReference type="PeptideAtlas" id="P09917"/>
<dbReference type="PRIDE" id="P09917"/>
<dbReference type="ProteomicsDB" id="52278">
<molecule id="P09917-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="7233"/>
<dbReference type="Antibodypedia" id="3906">
<property type="antibodies" value="749 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="240"/>
<dbReference type="Ensembl" id="ENST00000374391">
<molecule id="P09917-1"/>
<property type="protein sequence ID" value="ENSP00000363512"/>
<property type="gene ID" value="ENSG00000012779"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000542434">
<molecule id="P09917-2"/>
<property type="protein sequence ID" value="ENSP00000437634"/>
<property type="gene ID" value="ENSG00000012779"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000610656">
<molecule id="P09917-1"/>
<property type="protein sequence ID" value="ENSP00000484468"/>
<property type="gene ID" value="ENSG00000275565"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000622021">
<molecule id="P09917-2"/>
<property type="protein sequence ID" value="ENSP00000479958"/>
<property type="gene ID" value="ENSG00000275565"/>
</dbReference>
<dbReference type="GeneID" id="240"/>
<dbReference type="KEGG" id="hsa:240"/>
<dbReference type="UCSC" id="uc001jce.5">
<molecule id="P09917-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="240"/>
<dbReference type="DisGeNET" id="240"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000012779.10"/>
<dbReference type="GeneCards" id="ALOX5"/>
<dbReference type="HGNC" id="HGNC:435">
<property type="gene designation" value="ALOX5"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000012779">
<property type="expression patterns" value="Tissue enhanced (blood, bone marrow, lymphoid tissue)"/>
</dbReference>
<dbReference type="MalaCards" id="ALOX5"/>
<dbReference type="MIM" id="152390">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P09917"/>
<dbReference type="OpenTargets" id="ENSG00000012779"/>
<dbReference type="PharmGKB" id="PA46"/>
<dbReference type="eggNOG" id="ENOG502QQSP">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156111"/>
<dbReference type="HOGENOM" id="CLU_004282_3_3_1"/>
<dbReference type="InParanoid" id="P09917"/>
<dbReference type="KO" id="K00461"/>
<dbReference type="OMA" id="FPDMIKS"/>
<dbReference type="OrthoDB" id="385042at2759"/>
<dbReference type="PhylomeDB" id="P09917"/>
<dbReference type="TreeFam" id="TF105320"/>
<dbReference type="BioCyc" id="MetaCyc:HS00336-MONOMER"/>
<dbReference type="BRENDA" id="1.13.11.34">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="P09917"/>
<dbReference type="Reactome" id="R-HSA-2142688">
<property type="pathway name" value="Synthesis of 5-eicosatetraenoic acids"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2142691">
<property type="pathway name" value="Synthesis of Leukotrienes (LT) and Eoxins (EX)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2142700">
<property type="pathway name" value="Synthesis of Lipoxins (LX)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and Interleukin-13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6798695">
<property type="pathway name" value="Neutrophil degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9012546">
<property type="pathway name" value="Interleukin-18 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9018676">
<property type="pathway name" value="Biosynthesis of D-series resolvins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9018682">
<property type="pathway name" value="Biosynthesis of maresins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9018896">
<property type="pathway name" value="Biosynthesis of E-series 18(S)-resolvins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9020265">
<property type="pathway name" value="Biosynthesis of aspirin-triggered D-series resolvins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9023661">
<property type="pathway name" value="Biosynthesis of E-series 18(R)-resolvins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9026286">
<property type="pathway name" value="Biosynthesis of DPAn-3-derived protectins and resolvins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9026290">
<property type="pathway name" value="Biosynthesis of DPAn-3-derived maresins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9026403">
<property type="pathway name" value="Biosynthesis of DPAn-3-derived 13-series resolvins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9027604">
<property type="pathway name" value="Biosynthesis of electrophilic Omega-3 PUFA oxo-derivatives"/>
</dbReference>
<dbReference type="SABIO-RK" id="P09917"/>
<dbReference type="SIGNOR" id="P09917"/>
<dbReference type="UniPathway" id="UPA00877"/>
<dbReference type="BioGRID-ORCS" id="240">
<property type="hits" value="19 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="ALOX5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P09917"/>
<dbReference type="GeneWiki" id="Arachidonate_5-lipoxygenase"/>
<dbReference type="GenomeRNAi" id="240"/>
<dbReference type="Pharos" id="P09917">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P09917"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="RNAct" id="P09917">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000012779">
<property type="expression patterns" value="Expressed in blood and 222 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P09917">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P09917">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904813">
<property type="term" value="C:ficolin-1-rich granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005635">
<property type="term" value="C:nuclear envelope"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005641">
<property type="term" value="C:nuclear envelope lumen"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016363">
<property type="term" value="C:nuclear matrix"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031965">
<property type="term" value="C:nuclear membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034774">
<property type="term" value="C:secretory granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004051">
<property type="term" value="F:arachidonate 5-lipoxygenase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016787">
<property type="term" value="F:hydrolase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005506">
<property type="term" value="F:iron ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016702">
<property type="term" value="F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019369">
<property type="term" value="P:arachidonic acid metabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0036336">
<property type="term" value="P:dendritic cell migration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042593">
<property type="term" value="P:glucose homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051122">
<property type="term" value="P:hepoxilin biosynthetic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006959">
<property type="term" value="P:humoral immune response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035655">
<property type="term" value="P:interleukin-18-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002232">
<property type="term" value="P:leukocyte chemotaxis involved in inflammatory response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002523">
<property type="term" value="P:leukocyte migration involved in inflammatory response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901753">
<property type="term" value="P:leukotriene A4 biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019370">
<property type="term" value="P:leukotriene biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006691">
<property type="term" value="P:leukotriene metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002540">
<property type="term" value="P:leukotriene production involved in inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043651">
<property type="term" value="P:linoleic acid metabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0034440">
<property type="term" value="P:lipid oxidation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:2001301">
<property type="term" value="P:lipoxin biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019372">
<property type="term" value="P:lipoxygenase pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042759">
<property type="term" value="P:long-chain fatty acid biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016525">
<property type="term" value="P:negative regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001937">
<property type="term" value="P:negative regulation of endothelial cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050728">
<property type="term" value="P:negative regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903573">
<property type="term" value="P:negative regulation of response to endoplasmic reticulum stress"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903671">
<property type="term" value="P:negative regulation of sprouting angiogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061044">
<property type="term" value="P:negative regulation of vascular wound healing"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061045">
<property type="term" value="P:negative regulation of wound healing"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043312">
<property type="term" value="P:neutrophil degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030501">
<property type="term" value="P:positive regulation of bone mineralization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904999">
<property type="term" value="P:positive regulation of leukocyte adhesion to arterial endothelial cell"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900407">
<property type="term" value="P:regulation of cellular response to oxidative stress"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900015">
<property type="term" value="P:regulation of cytokine production involved in inflammatory response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045598">
<property type="term" value="P:regulation of fat cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050727">
<property type="term" value="P:regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0106014">
<property type="term" value="P:regulation of inflammatory response to wounding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050796">
<property type="term" value="P:regulation of insulin secretion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903426">
<property type="term" value="P:regulation of reactive oxygen species biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd01753">
<property type="entry name" value="PLAT_LOX"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000907">
<property type="entry name" value="LipOase"/>
</dbReference>
<dbReference type="InterPro" id="IPR013819">
<property type="entry name" value="LipOase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR036226">
<property type="entry name" value="LipOase_C_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR020834">
<property type="entry name" value="LipOase_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020833">
<property type="entry name" value="LipOase_Fe_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001885">
<property type="entry name" value="LipOase_mml"/>
</dbReference>
<dbReference type="InterPro" id="IPR001024">
<property type="entry name" value="PLAT/LH2_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036392">
<property type="entry name" value="PLAT/LH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR042062">
<property type="entry name" value="PLAT_LOX_verte"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11771">
<property type="entry name" value="PTHR11771"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00305">
<property type="entry name" value="Lipoxygenase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01477">
<property type="entry name" value="PLAT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00087">
<property type="entry name" value="LIPOXYGENASE"/>
</dbReference>
<dbReference type="PRINTS" id="PR00467">
<property type="entry name" value="MAMLPOXGNASE"/>
</dbReference>
<dbReference type="SMART" id="SM00308">
<property type="entry name" value="LH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48484">
<property type="entry name" value="SSF48484"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49723">
<property type="entry name" value="SSF49723"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00711">
<property type="entry name" value="LIPOXYGENASE_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00081">
<property type="entry name" value="LIPOXYGENASE_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51393">
<property type="entry name" value="LIPOXYGENASE_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50095">
<property type="entry name" value="PLAT"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0223">Dioxygenase</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0408">Iron</keyword>
<keyword id="KW-0434">Leukotriene biosynthesis</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<feature type="chain" description="Polyunsaturated fatty acid 5-lipoxygenase" id="PRO_0000220693">
<location>
<begin position="1"/>
<end position="674"/>
</location>
</feature>
<feature type="domain" description="PLAT" evidence="8">
<location>
<begin position="2"/>
<end position="118"/>
</location>
</feature>
<feature type="domain" description="Lipoxygenase" evidence="9">
<location>
<begin position="119"/>
<end position="674"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1; via carbonyl oxygen; structural" evidence="6">
<location>
<position position="17"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2; via carbonyl oxygen; structural" evidence="6">
<location>
<position position="18"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2; structural" evidence="6">
<location>
<position position="19"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2; structural" evidence="6">
<location>
<position position="44"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2; via carbonyl oxygen; structural" evidence="6">
<location>
<position position="45"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2; structural" evidence="6">
<location>
<position position="47"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1; via carbonyl oxygen; structural" evidence="6">
<location>
<position position="79"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1; via carbonyl oxygen; structural" evidence="6">
<location>
<position position="80"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron; via tele nitrogen; catalytic" evidence="1 2 3 4 23 24">
<location>
<position position="368"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron; via tele nitrogen; catalytic" evidence="1 2 3 4 23 24">
<location>
<position position="373"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron; via tele nitrogen; catalytic" evidence="1 2 3 4 23 24">
<location>
<position position="551"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron; catalytic" evidence="1 2 4 23 24">
<location>
<position position="555"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron; via carbonyl oxygen; catalytic" evidence="1 2 3 4 23 24">
<location>
<position position="674"/>
</location>
</feature>
<feature type="site" description="Essential for stabilizing binding to COTL1" evidence="20">
<location>
<position position="103"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPKAPK2" evidence="10 16">
<location>
<position position="272"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKA" evidence="11 28">
<location>
<position position="524"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_053534" evidence="35">
<location>
<begin position="424"/>
<end position="455"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_053535" evidence="35">
<original>ANATGGGGHVQMVQRAMKDLTYASLCFPEAIKARGMESKEDIPYYFYRDDGLLVWEAIRTFTAEVVDIYYEGDQVVEEDPELQDFVNDVYVYGMRGRKSSGFPKSVKSR</original>
<variation>VHGRGGRHLLRGRPGGGGGPGAAGLRERCLRVRHAGPQVLRLPQVGQEPGAAVGVPDRGDLHRLRPARRGQLRPAVPGHVPRRAFYREACEGSHGPIPQEPRGHCQRDC</variation>
<location>
<begin position="425"/>
<end position="533"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_053536" evidence="35">
<location>
<begin position="485"/>
<end position="674"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_053537" evidence="35">
<location>
<begin position="534"/>
<end position="674"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_046998" evidence="34 35">
<location>
<begin position="559"/>
<end position="615"/>
</location>
</feature>
<feature type="sequence variant" description="Decreases arachidonate 5-lipoxygenase activity. Increases leukotriene A4 synthase activity; dbSNP:rs2228065." id="VAR_028018" evidence="12 26">
<original>E</original>
<variation>K</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence variant" description="Decreases arachidonate 5-lipoxygenase activity." id="VAR_083301" evidence="26">
<original>P</original>
<variation>S</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="sequence variant" description="Increases arachidonate 5-lipoxygenase activity." id="VAR_083302" evidence="26">
<original>A</original>
<variation>S</variation>
<location>
<position position="447"/>
</location>
</feature>
<feature type="sequence variant" description="Decreases arachidonate 5-lipoxygenase activity." id="VAR_083303" evidence="26">
<original>A</original>
<variation>V</variation>
<location>
<position position="549"/>
</location>
</feature>
<feature type="sequence variant" description="Does not affect arachidonate 5-lipoxygenase activity." id="VAR_083304" evidence="26">
<original>P</original>
<variation>L</variation>
<location>
<position position="577"/>
</location>
</feature>
<feature type="sequence variant" description="Increases arachidonate 5-lipoxygenase activity. Does not affect leukotriene A4 synthase activity." id="VAR_083305" evidence="26">
<original>T</original>
<variation>M</variation>
<location>
<position position="591"/>
</location>
</feature>
<feature type="sequence variant" description="Increases arachidonate 5-lipoxygenase activity." id="VAR_083306" evidence="26">
<original>K</original>
<variation>Q</variation>
<location>
<position position="656"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with DICER1; when associated with A-76 and A-103." evidence="17">
<original>W</original>
<variation>A</variation>
<location>
<position position="14"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with DICER1; when associated with A-14 and A-103." evidence="17">
<original>W</original>
<variation>A</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to COTL1. Impairs interaction with DICER; when associated with A-14 and A-76." evidence="17 20">
<original>W</original>
<variation>A</variation>
<location>
<position position="103"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation site. Permits export from the nucleus." evidence="16">
<original>S</original>
<variation>A</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="mutagenesis site" description="No loss of activity.">
<original>D</original>
<variation>N</variation>
<location>
<position position="359"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of (5S)-lipoxygenase activity; when associated with I-425 and M-426. Loss of (5S)-lipoxygenase activity; when associated with I-425; M-426 and I-604. Exhibits a major (15S)-lipoxygenase activity; when associated with I-425 and M-426. Exhibits a major (15S)-lipoxygenase activity; when associated with I-425; M-426 and I-604. Does not catalyze oxygenation of arachodonic acid to 5-HETE; when associated with I-425: M-426 and I-604. Catalyzes oxygenation of arachodonic acid to form mostly (15S)-HETE and (8S)-HETE but also 12-HETE; when associated with I-425: M-426 and I-604. Abolishes the LTA4-synthase activity; when associated with I-425: M-426 and I-604. Catalyzes oxygenation of linoleic acid to (13S)- and (9S)-HODE; when associated with I-425: M-426 and I-604. Catalyzes oxygenation of (11S)- and (11R)-deutero-linoleic acid to 9-HODE and (13S)-HODE respectively; when associated with I-425: M-426 and I-604. Catalyzes oxygenation of alpha-linolenic acid (ALA) to 13-HOTrE(n-3); when associated with I-425: M-426 and I-604. Catalyzes oxygenation of gamma-linolenic acid (GLA) to 13-HOTrE(n-6) and 10-HOTrE; when associated with I-425: M-426 and I-604. Catalyzes the oxygenation of eicosapentaenoic acid (EPA) to 12- and 15-HEPA; when associated with I-425: M-426 and I-604. Catalyzes the oxygenation of docosahexaenoic acid (DHA) to 10- and 17-HDHA; when associated with I-425: M-426 and I-604. Exhibits a lipoxin synthase activity towards (5S)-HETE as major substrates followed by (5S),(15S)-DiHETE and (15S)-HETE; when associated with I-425: M-426 and I-604." evidence="25 30">
<original>F</original>
<variation>W</variation>
<location>
<position position="360"/>
</location>
</feature>
<feature type="mutagenesis site" description="Still some substantial activity." evidence="19">
<original>H</original>
<variation>S</variation>
<variation>N</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="mutagenesis site" description="No activity." evidence="13 19">
<original>H</original>
<variation>S</variation>
<variation>N</variation>
<variation>A</variation>
<location>
<position position="368"/>
</location>
</feature>
<feature type="mutagenesis site" description="No activity." evidence="13 19">
<original>H</original>
<variation>S</variation>
<variation>N</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="mutagenesis site" description="No activity." evidence="13">
<original>E</original>
<variation>Q</variation>
<location>
<position position="377"/>
</location>
</feature>
<feature type="mutagenesis site" description="No activity." evidence="13 19">
<original>H</original>
<variation>A</variation>
<location>
<position position="391"/>
</location>
</feature>
<feature type="mutagenesis site" description="Still some substantial activity." evidence="13 19">
<original>H</original>
<variation>S</variation>
<variation>N</variation>
<location>
<position position="391"/>
</location>
</feature>
<feature type="mutagenesis site" description="No activity." evidence="13 19">
<original>H</original>
<variation>A</variation>
<location>
<position position="400"/>
</location>
</feature>
<feature type="mutagenesis site" description="Still some substantial activity." evidence="13 19">
<original>H</original>
<variation>S</variation>
<variation>N</variation>
<location>
<position position="400"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of (5S)-lipoxygenase activity; when associated with W-360 and M-426. Loss of (5S)-lipoxygenase activity; when associated with W-360; M-426 and I-604. Exhibits a major (15S)-lipoxygenase activity; when associated with W-360 and M-426. Exhibits a major (15S)-lipoxygenase activity; when associated with W-360; M-426 and I-604. Does not catalyze oxygenation of arachodonic acid to 5-HETE; when associated with W-360; M-426 and I-604. Catalyzes oxygenation of arachodonic acid to form in majority (15S)-HETE and (8S)-HETE but also 12-HETE; when associated with W-360; M-426 and I-604. Abolishes the LTA4-synthase activity; when associated with W-360; M-426 and I-604. Catalyzes oxygenation of linoleic acid to (13S)- and (9S)-HODE; when associated with W-360; M-426 and I-604. Catalyzes oxygenation of (11S)- and (11R)-deutero-linoleic acid to 9-HODE and (13S)-HODE respectively; when associated with W-360; M-426 and I-604. Catalyzes oxygenation of alpha-linolenic acid (ALA) to 13-HOTrE(n-3); when associated with W-360; M-426 and I-604. Catalyzes oxygenation of gamma-linolenic acid (GLA) to 13-HOTrE(n-6) and 10-HOTrE; when associated with W-360; M-426 and I-604. Catalyzes the oxygenation of eicosapentaenoic acid (EPA) to 12- and 15-HEPA; when associated with W-360; M-426 and I-604. Catalyzes the oxygenation of docosahexaenoic acid (DHA) to 10- and 17-HDHA; when associated with W-360; M-426 and I-604. Exhibits a lipoxin synthase activity towards (5S)-HETE as major substrates followed by (5S),(15S)-DiHETE and (15S)-HETE; when associated with W-360; M-426 and I-604." evidence="25 30">
<original>A</original>
<variation>I</variation>
<location>
<position position="425"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of (5S)-lipoxygenase activity; when associated with W-360 and I-425. Loss of (5S)-lipoxygenase activity; when associated with W-360; I-425 and I-604. Exhibits a major (15S)-lipoxygenase activity; when associated with W-360 and I-425. Exhibits a major (15S)-lipoxygenase activity; when associated with W-360; I-425 and I-604. Does not catalyze oxygenation of arachodonic acid to 5-HETE; when associated with W-360; I-425 and I-604. Catalyzes oxygenation of arachodonic acid to form in majority (15S)-HETE and (8S)-HETE but also 12-HETE; when associated with W-360; I-425 and I-604. Abolishes the LTA4-synthase activity; when associated with W-360; I-425 and I-604. Catalyzes oxygenation of linoleic acid to (13S)- and (9S)-HODE; when associated with W-360; I-425 and I-604. Catalyzes oxygenation of (11S)- and (11R)-deutero-linoleic acid to 9-HODE and (13S)-HODE respectively; when associated with W-360; I-425 and I-604. Catalyzes oxygenation of alpha-linolenic acid (ALA) to 13-HOTrE(n-3); when associated with W-360; I-425 and I-604. Catalyzes oxygenation of gamma-linolenic acid (GLA) to 13-HOTrE(n-6) and 10-HOTrE; when associated with W-360; I-425 and I-604. Catalyzes the oxygenation of eicosapentaenoic acid (EPA) to 12- and 15-HEPA; when associated with W-360; I-425 and I-604. Catalyzes the oxygenation of docosahexaenoic acid (DHA) to 10- and 17-HDHA; when associated with W-360; I-425 and I-604. Exhibits a lipoxin synthase activity towards (5S)-HETE as major substrates followed by (5S),(15S)-DiHETE and (15S)-HETE; when associated with W-360; I-425 and I-604." evidence="25 30">
<original>N</original>
<variation>M</variation>
<location>
<position position="426"/>
</location>
</feature>
<feature type="mutagenesis site" description="Almost no loss of activity.">
<original>H</original>
<variation>N</variation>
<variation>A</variation>
<location>
<position position="433"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents phosphorylation by PKA." evidence="11">
<original>S</original>
<variation>A</variation>
<location>
<position position="524"/>
</location>
</feature>
<feature type="mutagenesis site" description="No activity." evidence="13">
<original>H</original>
<variation>N</variation>
<variation>A</variation>
<location>
<position position="551"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of (5S)-lipoxygenase activity. Loss of (5S)-lipoxygenase activity; when associated with W-360; I-425 and M-426. Exhibits a major (15S)-lipoxygenase activity;when associated with W-360; I-425 and M-426. Does not catalyze oxygenation of arachodonic acid to 5-HETE; when associated with W-360; I-425 and M-426. Catalyzes oxygenation of arachodonic acid to form in majority (15S)-HETE and (8S)-HETE but also 12-HETE; when associated with W-360; I-425 and M-426. Abolishes the LTA4-synthase activity; when associated with W-360; I-425 and M-426. Catalyzes oxygenation of linoleic acid to (13S)- and (9 S)-HODE; when associated with W-360; I-425 and M-426. Catalyzes oxygenation of (11S)- and (11R)-deutero-linoleic acid to 9-HODE and (13S)-HODE respectively; when associated with W-360; I-425 and M-426. Catalyzes oxygenation of alpha-linolenic acid (ALA) to 13-HOTrE(n-3); when associated with W-360; I-425 and M-426. Catalyzes oxygenation of gamma-linolenic acid (GLA) to 13-HOTrE(n-6) and 10-HOTrE; when associated with W-360; I-425 and M-426. Catalyzes the oxygenation of eicosapentaenoic acid (EPA) to 12- and 15-HEPA; when associated with W-360; I-425 and M-426. Catalyzes the oxygenation of docosahexaenoic acid (DHA) to 10- and 17-HDHA; when associated with W-360; I-425 and M-426. Exhibits a lipoxin synthase activity towards (5S)-HETE as major substrates followed by (5S),(15S)-DiHETE and (15S)-HETE; when associated with W-360; I-425 and M-426." evidence="25 30">
<original>A</original>
<variation>I</variation>
<location>
<position position="604"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect arachidonate 5-lipoxygenase activity. Does not oxygenate arachidonate typical 15-lipoxygenase substrates such as dihomo-gamma-linolenic acid and N-arachidonyl glycine." evidence="24">
<original>S</original>
<variation>A</variation>
<location>
<position position="664"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhances affinity for arachidonic acid. Impairs arachidonate 5-lipoxygenase activity. Induces arachidonate 15-lipoxygenase activity. Oxygenates typical arachidonate 15-lipoxygenase substrates such as dihomo-gamma-linolenic acid and N-arachidonyl glycine. Synthesizes lipoxin A4 when incubated with a stable 5-lipoxygenase." evidence="24">
<original>S</original>
<variation>D</variation>
<location>
<position position="664"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="4"/>
<end position="10"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="20"/>
<end position="30"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="36"/>
<end position="38"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="51"/>
<end position="56"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="64"/>
<end position="73"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="75"/>
<end position="77"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="81"/>
<end position="89"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="95"/>
<end position="104"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="106"/>
<end position="108"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="110"/>
<end position="113"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="120"/>
<end position="122"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="126"/>
<end position="142"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="155"/>
<end position="157"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="161"/>
<end position="163"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="166"/>
<end position="168"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="171"/>
<end position="176"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="178"/>
<end position="188"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="192"/>
<end position="194"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="205"/>
<end position="212"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="213"/>
<end position="215"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="218"/>
<end position="226"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="230"/>
<end position="239"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="260"/>
<end position="263"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="264"/>
<end position="266"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="273"/>
<end position="278"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="282"/>
<end position="286"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="288"/>
<end position="290"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="297"/>
<end position="300"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="303"/>
<end position="306"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="310"/>
<end position="315"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="321"/>
<end position="331"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="333"/>
<end position="336"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="345"/>
<end position="365"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="366"/>
<end position="372"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="373"/>
<end position="386"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="392"/>
<end position="397"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="398"/>
<end position="400"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="404"/>
<end position="414"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="421"/>
<end position="423"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="427"/>
<end position="431"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="432"/>
<end position="441"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="447"/>
<end position="449"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="451"/>
<end position="457"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="463"/>
<end position="465"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="470"/>
<end position="493"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="497"/>
<end position="501"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="504"/>
<end position="515"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="516"/>
<end position="520"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="522"/>
<end position="524"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="533"/>
<end position="547"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="549"/>
<end position="555"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="558"/>
<end position="562"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="565"/>
<end position="567"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="572"/>
<end position="574"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="579"/>
<end position="581"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="585"/>
<end position="591"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="595"/>
<end position="608"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="629"/>
<end position="653"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="656"/>
<end position="658"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="665"/>
<end position="667"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="669"/>
<end position="671"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3O8Y"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3V92"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3V98"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3V99"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6NCF"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250"/>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P48999"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00152"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00726"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11844797"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15280375"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15308583"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1540191"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16275640"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17114001"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18978352"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19022417"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19233132"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1939225"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19807693"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21200133"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21206090"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21233389"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22516296"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23246375"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24282679"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24893149"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26210919"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3118366"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31664810"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8245774"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8615788"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8631361"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="21098726"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="3422434"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000305"/>
<evidence key="38" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="17114001"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21206090"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="23246375"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="31664810"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="8631361"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:435"/>
</source>
</evidence>
<sequence length="674" mass="77983" checksum="36F38C0A9E86BB21" modified="2007-01-23" version="2">MPSYTVTVATGSQWFAGTDDYIYLSLVGSAGCSEKHLLDKPFYNDFERGAVDSYDVTVDEELGEIQLVRIEKRKYWLNDDWYLKYITLKTPHGDYIEFPCYRWITGDVEVVLRDGRAKLARDDQIHILKQHRRKELETRQKQYRWMEWNPGFPLSIDAKCHKDLPRDIQFDSEKGVDFVLNYSKAMENLFINRFMHMFQSSWNDFADFEKIFVKISNTISERVMNHWQEDLMFGYQFLNGCNPVLIRRCTELPEKLPVTTEMVECSLERQLSLEQEVQQGNIFIVDFELLDGIDANKTDPCTLQFLAAPICLLYKNLANKIVPIAIQLNQIPGDENPIFLPSDAKYDWLLAKIWVRSSDFHVHQTITHLLRTHLVSEVFGIAMYRQLPAVHPIFKLLVAHVRFTIAINTKAREQLICECGLFDKANATGGGGHVQMVQRAMKDLTYASLCFPEAIKARGMESKEDIPYYFYRDDGLLVWEAIRTFTAEVVDIYYEGDQVVEEDPELQDFVNDVYVYGMRGRKSSGFPKSVKSREQLSEYLTVVIFTASAQHAAVNFGQYDWCSWIPNAPPTMRAPPPTAKGVVTIEQIVDTLPDRGRSCWHLGAVWALSQFQENELFLGMYPEEHFIEKPVKEAMARFRKNLEAIVSVIAERNKKKQLPYYYLSPDRIPNSVAI</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

